Emergence of dual-resistance HBV mutations to adefovir-dipivoxil and lamivudine in a hepatitis B patient with combination therapy for adefovir resistance

被引：0
|
作者：
Kwon, S. Y.
Lee, C. H.
Choi, W. H.
Yeon, J. E.
Byun, K. S.
机构：
[1] Konkuk Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80741-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
740
引用
收藏
页码：S273 / S274
页数：2
相关论文
共 50 条
  • [1] Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
    Yeon, J. E.
    Yoo, W.
    Hong, S. P.
    Chang, Y. J.
    Yu, S. K.
    Kim, J. H.
    Seo, Y. S.
    Chung, H. J.
    Moon, M. S.
    Kim, S-O
    Byun, K. S.
    Lee, C. H.
    GUT, 2006, 55 (10) : 1488 - 1495
  • [2] Adefovir dipivoxil/lamivudineDevelopement of adefovir dipivoxil and lamivudine resistance in hepatitis B cirrhosis: case report
    Reactions Weekly, 2017, 1678 (1) : 14 - 14
  • [3] Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B
    van der Poorten, David
    Prakoso, Emilia
    Khoo, Teh-Liane
    Ngu, Meng C.
    McCaughan, Geoffrey W.
    Strasser, Simone I.
    Lee, Alice U.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (09) : 1500 - 1505
  • [4] Adefovir-dipivoxil/entecavir/lamivudine/telbivudineDrug resistance: 4 case reports
    Reactions Weekly, 2020, 1817 (1) : 19 - 19
  • [5] Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B
    Liu, Yan
    Wang, Chunmei
    Zhong, Yanwei
    Chen, Li
    Li, Xiaodong
    Ji, Dong
    Wang, Huifen
    Xin, Shaojie
    Zoulim, Fabien
    Xu, Dongping
    ANTIVIRAL THERAPY, 2010, 15 (08) : 1185 - 1190
  • [6] Combination of adefovir dipivoxil (ADV) and lamivudine (LAM) prevented emergence of ADV resistance mutations in chronic hepatitis B (CHB) patients with LAM-Resistant HBV
    Snow, A
    Thibault, V
    Qi, XP
    Zhu, Y
    Westland, C
    Arterburn, S
    Benhamou, Y
    Currie, G
    Brosgart, CL
    Miller, MD
    Xiong, S
    GASTROENTEROLOGY, 2005, 128 (04) : A745 - A745
  • [7] Adefovir-dipivoxil/lamivudineDrug resistance: case report
    Reactions Weekly, 2019, 1750 (1) : 20 - 20
  • [8] The combination of lamivudine and adefovir prevents both lamivudine and adefovir resistance in patients with chronic hepatitis B
    Hezode, Christophe
    Dhalluin-Venier, Valerie
    Chevaliez, Stephane
    Roudot-Thoraval, Francoise
    Mallat, Ariane
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2008, 134 (04) : A810 - A810
  • [9] Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
    Perrillo, Robert P.
    Hann, Hie-Won
    Schiff, Eugene
    Mutimer, David
    Willems, Bernard
    Leung, Nancy
    Lee, William M.
    Dixon, Susan
    Woessner, Mary
    Brosgart, Carol L.
    Condreay, Lynn D.
    Gardner, Stephen D.
    HEPATOLOGY INTERNATIONAL, 2011, 5 (02) : 654 - 663
  • [10] Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
    Chen, YongFa
    Ju, Ting
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : E152 - E158
12345